Marcus Dieterle

I lead discovery research across our three sites in Copenhagen, Basel and Boston, with a team of just over 600 scientists.

My own background is in protein engineering — I spent the first decade of my career designing long-acting peptide analogues, several of which are now marketed products.

At Exxopharm I have pushed to combine physical laboratory work with computational screening, which has shortened our lead-optimisation cycle from years to months.

I believe good science needs long horizons and honest failure reporting, and I spend a large part of my time making sure our teams feel safe to stop a programme that is not working.